Literature DB >> 19064330

A novel molecular aspect of Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD): c.449-452delCTGA is a common mutation in Japanese patients with MCADD.

Jamiyan Purevsuren1, Hironori Kobayashi, Yuki Hasegawa, Yuichi Mushimoto, Hong Li, Seiji Fukuda, Yosuke Shigematsu, Toshiyuki Fukao, Seiji Yamaguchi.   

Abstract

We studied 11 Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD) and found a common mutation, c.449-452delCTGA, which accounted for 45% of the mutations. Seven of 10 independent patients carried at least one copy of this mutation. Phenotypes of homozygous patients with the c.449-452delCTGA mutation varied from asymptomatic to life-threatening metabolic decompensation in Japanese patients with MCADD, similar to the phenotypic variations in Caucasians. This study suggests the genotypic difference between those of Caucasians and Japanese regarding MCADD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064330     DOI: 10.1016/j.ymgme.2008.10.012

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variants.

Authors:  Kira-Lee Koster; Marga Sturm; Diran Herebian; Sander H J Smits; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2014-06-26       Impact factor: 4.982

2.  Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Hye In Woo; Hyung-Doo Park; Yong-Wha Lee; Dong Hwan Lee; Chang-Seok Ki; Soo-Youn Lee; Jong-Won Kim
Journal:  Korean J Lab Med       Date:  2011-01

3.  Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.

Authors:  Sze Chern Lim; Makiko Tajika; Masaru Shimura; Kirstyn T Carey; David A Stroud; Kei Murayama; Akira Ohtake; Matthew McKenzie
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

4.  Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.

Authors:  Eungu Kang; Yoon-Myung Kim; Minji Kang; Sun-Hee Heo; Gu-Hwan Kim; In-Hee Choi; Jin-Ho Choi; Han-Wook Yoo; Beom Hee Lee
Journal:  BMC Pediatr       Date:  2018-03-08       Impact factor: 2.125

5.  Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients.

Authors:  Zhuwen Gong; Lili Liang; Wenjuan Qiu; Huiwen Zhang; Jun Ye; Yu Wang; Wenjun Ji; Ting Chen; Xuefan Gu; Lianshu Han
Journal:  Front Genet       Date:  2021-03-23       Impact factor: 4.599

6.  MCAD deficiency caused by compound heterozygous pathogenic variants in ACADM.

Authors:  Fumikatsu Nohara; Go Tajima; Hideo Sasai; Yoshio Makita
Journal:  Hum Genome Var       Date:  2022-01-17

7.  Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.

Authors:  Maria Luz Couce; Paula Sánchez-Pintos; Luisa Diogo; Elisa Leão-Teles; Esmeralda Martins; Helena Santos; Maria Amor Bueno; Carmen Delgado-Pecellín; Daisy E Castiñeiras; José A Cocho; Judit García-Villoria; Antonia Ribes; José M Fraga; Hugo Rocha
Journal:  Orphanet J Rare Dis       Date:  2013-07-10       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.